Methotrexate
At high concentrations methotrexate and its 7-hydroxy metabolite
may cause tubular nephropathy.
- Overview
- Hydration Process
- Urine Alkalinisation
- Post Hydration
Overview
Methotrexate and its 7-hydroxy metabolite are not very soluble in acid pH. At high concentrations they may precipitate in the renal tubules causing damage (tubular nephropathy). A high fluid throughput and alkalinisation of the urine to pH 6.5 - 7 is required to minimise this.
Depending on the protocol being used high dose methotrexate may be administered over a period of 3-4 hours or 24 hours.
Why Alkalinise?
Alkalinising the urine increases the solubility of methotrexate and its 7-hydroxy metabolite, promotes excretion and reduces damage.
Hydration Process
Patients receiving methotrexate high dose (doses > 250mg/m2) should be well hydrated prior to its administration and hydration maintained until the methotrexate levels have fallen to 0.2micromol/l. Levels are not usually measured for patients receiving doses less than 500mg/m2.
In adult patients a couple of litres of fluid (usually Sodium chloride 0.9% with potassium 20mmol/l) over 4 hours are usually prescribed.
In paediatric patients where a much closer eye is kept on fluid balance, an intravenous intake of 125ml/m2/hr is considered to be adequate.
Urine Alkalinisation
Urine alkalinisation may be carried out by:
The urine pH is kept at >7.0 throughout administration of the methotrexate and for a minimum of 48 hours post dose.
Reference
Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate.
Samash J, Earl H, Rouhami R.
Cancer Chemother Pharmacol 1991, 28: 150-151
Post Hydration
Post hydration is continued for 24-28 hours and a combined oral and/or intravenous intake greater than 3l/m2/24 hours maintained until the methotrexate levels are below 0.2µmol/l.